The DOI matches its Crossref record; 292 of the 292 references it cites were found in a registry or an index.
Virulence factors in Escherichia coli urinary tract infection
Open accessAbstract
Uropathogenic strains of Escherichia coli are characterized by the expression of distinctive bacterial properties, products, or structures referred to as virulence factors because they help the organism overcome host defenses and colonize or invade the urinary tract. Virulence factors of recognized importance in the pathogenesis of urinary tract infection (UTI) include adhesins (P fimbriae, certain other mannose-resistant adhesins, and type 1 fimbriae), the aerobactin system, hemolysin, K capsule, and resistance to serum killing. This review summarizes the virtual explosion of information regarding the epidemiology, biochemistry, mechanisms of action, and genetic basis of these urovirulence factors that has occurred in the past decade and identifies areas in need of further study. Virulence factor expression is more common among certain genetically related groups of E. coli which constitute virulent clones within the larger E. coli population. In general, the more virulence factors a strain expresses, the more severe an infection it is able to cause. Certain virulence factors specifically favor the development of pyelonephritis, others favor cystitis, and others favor asymptomatic bacteriuria. The currently defined virulence factors clearly contribute to the virulence of wild-type strains but are usually insufficient in themselves to transform an avirulent organism into a pathogen, demonstrating that other as-yet-undefined virulence properties await discovery. Virulence factor testing is a useful epidemiological and research tool but as yet has no defined clinical role. Immunological and biochemical anti-virulence factor interventions are effective in animal models of UTI and hold promise for the prevention of UTI in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weinberg, E. D. (1978) · Microbiological Reviews · doi:10.1128/mmbr.42.1.45-66.1978 · Cited by 1,254
Gros, P., Croop, J., & Housman, D. (1986) · Cell · doi:10.1016/0092-8674(86)90594-5 · Cited by 1,031
ANTI-ESCHERICHIA COLI ALPHA-HAEMOLYSIN IN CONTROL AND PATIENT SERA
Emody, L., Batai, I., Kerényi, M., Székely, J., & Polyak, L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90183-0 · Cited by 800
Brinton, C. C. (1965) · Transactions of the New York Academy of Sciences · doi:10.1111/j.2164-0947.1965.tb02342.x · Cited by 763
Gerlach, J. H., Endicott, J. A., Juranka, P. F., Henderson, G., Sarangi, F., Deuchars, K. L., & Ling, V. (1986) · Nature · doi:10.1038/324485a0 · Cited by 667
Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors
OFEK, I., MIRELMAN, D., & SHARON, N. (1977) · Nature · doi:10.1038/265623a0 · Cited by 665
Bagg, A., & Neilands, J. B. (1987) · Biochemistry · doi:10.1021/bi00391a039 · Cited by 593 · cited 7×
“49 94/149 (63) 161 13/44 (30) 302 14/115 (12) 38/170 (22) 340/709 (48) 307 82/119 (69) 78/109 (72) 14/113 (12) 174/341 (51) 316 94/186 (50)d 23/59 (39) 72/277 (23) 189/552 (36)" 317 85/122 (70)d 85/122 (70)d 338 36/52 (69) 28/41 (68) 64/93 (69) 343 26/61 (43) 397 94/149 (63) 71/101 (70) 22/116 (19) 187/366 (51) 64/102…”
BackgroundInfluentialHull, R. A., Gill, R. E., Hsu, P., Minshew, B. H., & Falkow, S. (1981) · Infection and Immunity · doi:10.1128/iai.33.3.933-938.1981 · Cited by 588
Nucleotide sequence of an Escherichia coli chromosomal hemolysin
Felmlee, T., Pellett, S., & Welch, R. A. (1985) · Journal of Bacteriology · doi:10.1128/jb.163.1.94-105.1985 · Cited by 545
Leffler, H., & Edén, C. S. (1980) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1980.tb05064.x · Cited by 513
Cited by
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583
Foxman, B., Barlow, R., D'Arcy, H., Gillespie, B., & Sobel, J. D. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(00)00072-7 · Cited by 1,447
Johnson, J. R., & Stell, A. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315217 · Cited by 1,269
Self-citationPresence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease
Darfeuille-Michaud, A., Neut, C., Barnich, N., Lederman, E., Di Martino, P., Desreumaux, P., Gambiez, L., Joly, B., Cortot, A., & Colombel, J.-F. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70019-8 · Cited by 877
Jacobsen, S. M., Stickler, D. J., Mobley, H. L. T., & Shirtliff, M. E. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-07 · Cited by 814
Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.
Connell, I., Agace, W., Klemm, P., Schembri, M., Mărild, S., & Svanborg, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9827 · Cited by 735
Sarowska, J., Futoma-Koloch, B., Jama-Kmiecik, A., Frej-Madrzak, M., Ksiazczyk, M., Bugla-Ploskonska, G., & Choroszy-Krol, I. (2019) · Gut Pathogens · doi:10.1186/s13099-019-0290-0 · Cited by 718
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
Rogers, B. A., Sidjabat, H. E., & Paterson, D. L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq415 · Cited by 716
Russo, T. A., & Johnson, J. R. (2000) · The Journal of Infectious Diseases · doi:10.1086/315418 · Cited by 652
Self-citationOrigins and virulence mechanisms of uropathogenic Escherichia coli
Wiles, T. J., Kulesus, R. R., & Mulvey, M. A. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.03.007 · Cited by 606
Rodriguez-Mateos, A., Vauzour, D., Krueger, C. G., Shanmuganayagam, D., Reed, J., Calani, L., Mena, P., Del Rio, D., & Crozier, A. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1330-7 · Cited by 602
Risk Factors for Recurrent Urinary Tract Infection in Young Women
Scholes, D., Hooton, T. M., Roberts, P. L., Stapleton, A. E., Gupta, K., & Stamm, W. E. (2000) · The Journal of Infectious Diseases · doi:10.1086/315827 · Cited by 550
Multivalent glycoconjugates as anti-pathogenic agents
Bernardi, A., Jiménez-Barbero, J., Casnati, A., De Castro, C., Darbre, T., Fieschi, F., Finne, J., Funken, H., Jaeger, K.-E., Lahmann, M., et al. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35408j · Cited by 537
Tambyah, P. A., & Maki, D. G. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.5.678 · Cited by 537
Manges, A. R., Johnson, J. R., Foxman, B., O'Bryan, T. T., Fullerton, K. E., & Riley, L. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011265 · Cited by 531
Self-citationKaper, J. B. (2005) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.06.008 · Cited by 486
Recurrent urinary tract infection in women
Hooton, T. M. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00350-2 · Cited by 472
Mulvey, M. A., Schilling, J. D., Martinez, J. J., & Hultgren, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8829 · Cited by 468
Use of Lactobacillus to prevent infection by pathogenic bacteria
Reid, G., & Burton, J. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01544-7 · Cited by 445
Iron uptake mechanisms of pathogenic bacteria
Wooldridge, K. (1993) · FEMS Microbiology Reviews · doi:10.1016/0168-6445(93)90011-w · Cited by 433
Rodriguez-Siek, K. E., Giddings, C. W., Doetkott, C., Johnson, T. J., Fakhr, M. K., & Nolan, L. K. (2005) · Microbiology · doi:10.1099/mic.0.27499-0 · Cited by 432
Extraintestinal pathogenic Escherichia coli : “The other bad E coli ”
Johnson, J. R., & Russo, T. A. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.121550 · Cited by 420
Self-citationBlum, G., Ott, M., Lischewski, A., Ritter, A., Imrich, H., Tschäpe, H., & Hacker, J. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.606-614.1994 · Cited by 413
The structures of Escherichia coli O-polysaccharide antigens
Stenutz, R., Weintraub, A., & Widmalm, G. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00016.x · Cited by 406
Phylogenetic Distribution of Extraintestinal Virulence‐Associated Traits in Escherichia coli
Johnson, J. R., Delavari, P., Kuskowski, M., & Stell, A. L. (2001) · The Journal of Infectious Diseases · doi:10.1086/317656 · Cited by 400
Self-citationAdhesion and entry of uropathogenic Escherichia coli
Mulvey, M. A. (2002) · Cellular Microbiology · doi:10.1046/j.1462-5822.2002.00193.x · Cited by 394
Ikahelmo, R., Siitonen, A., Heiskanen, T., Karkkainen, U., Kuosmanen, P., Lipponen, P., & Makela, P. H. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.1.91 · Cited by 364
Bien, J., Sokolova, O., & Bozko, P. (2012) · International Journal of Nephrology · doi:10.1155/2012/681473 · Cited by 361
Uroplakins in urothelial biology, function, and disease
Wu, X.-R., Kong, X.-P., Pellicer, A., Kreibich, G., & Sun, T.-T. (2009) · Kidney International · doi:10.1038/ki.2009.73 · Cited by 354
Brzuszkiewicz, E., Brüggemann, H., Liesegang, H., Emmerth, M., Ölschläger, T., Nagy, G., Albermann, K., Wagner, C., Buchrieser, C., Emődy, L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603038103 · Cited by 351
Le Bouguenec, C., Archambaud, M., & Labigne, A. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.5.1189-1193.1992 · Cited by 341
Shankar, N., Lockatell, C. V., Baghdayan, A. S., Drachenberg, C., Gilmore, M. S., & Johnson, D. E. (2001) · Infection and Immunity · doi:10.1128/iai.69.7.4366-4372.2001 · Cited by 341
Potential virulence factors of Proteus bacilli.
Rózalski, A., Sidorczyk, Z., & Kotełko, K. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.1.65-89.1997 · Cited by 337
Urinary Tract Infections in Females
Kunin, C. M. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.1.1 · Cited by 328
BACTERIAL VIRULENCE IN URINARY TRACT INFECTION
Svanborg, C., & Godaly, G. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70371-8 · Cited by 305
A Prospective Study of Asymptomatic Bacteriuria in Sexually Active Young Women
Hooton, T. M., Scholes, D., Stapleton, A. E., Roberts, P. L., Winter, C., Gupta, K., Samadpour, M., & Stamm, W. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431402 · Cited by 304
Adlerberth, I., Ahrne, S., Johansson, M. L., Molin, G., Hanson, L. A., & Wold, A. E. (1996) · Applied and Environmental Microbiology · doi:10.1128/aem.62.7.2244-2251.1996 · Cited by 293
Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules
Cress, B. F., Englaender, J. A., He, W., Kasper, D., Linhardt, R. J., & Koffas, M. A. G. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12056 · Cited by 282
“However, purified CPSs from some of the most commonly isolated strains were determined to be nonimmunogenic due to structural identity with human glycans (Edwards et al., 1982; Johnson, 1991; H!erias et al., 1997).”
BackgroundTorres, A. G., Redford, P., Welch, R. A., & Payne, S. M. (2001) · Infection and Immunity · doi:10.1128/iai.69.10.6179-6185.2001 · Cited by 287
Lane, M. C., & Mobley, H. L. T. (2007) · Kidney International · doi:10.1038/sj.ki.5002230 · Cited by 286
Yamamoto, S., Tsukamoto, T., Terai, A., Kurazono, H., Takeda, Y., & Yoshida, O. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65154-1 · Cited by 281
Chassaing, B., Rolhion, N., Vallée, A. D., Salim, S. Y., Prorok-Hamon, M., Neut, C., Campbell, B. J., Söderholm, J. D., Hugot, J.-P., Colombel, J.-F., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44632 · Cited by 265
Bingen, E., Picard, B., Brahimi, N., Mathy, S., Desjardins, P., Elion, J., & Denamur, E. (1998) · The Journal of Infectious Diseases · doi:10.1086/514217 · Cited by 256
The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic
Sonnenborn, U., & Schulze, J. (2009) · Microbial Ecology in Health and Disease · doi:10.3109/08910600903444267 · Cited by 232
Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications
Bäckhed, F., Normark, S., Schweda, E. K. H., Oscarson, S., & Richter-Dahlfors, A. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00207-7 · Cited by 177
Nowrouzian, F., Hesselmar, B., Saalman, R., Strannegård, I.-L., Åberg, N., Wold, A. E., & Adlerberth, I. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000069843.20655.ee · Cited by 176
Skyberg, J. A., Johnson, T. J., Johnson, J. R., Clabots, C., Logue, C. M., & Nolan, L. K. (2006) · Infection and Immunity · doi:10.1128/iai.00363-06 · Cited by 162
Self-citationFranz, M., & Hörl, W. H. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.11.2746 · Cited by 100
Bäckhed, F., Alsén, B., Roche, N., Ångström, J., von Euler, A., Breimer, M. E., Westerlund-Wikström, B., Teneberg, S., & Richter-Dahlfors, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111640200 · Cited by 96
Selvarangan, R., Goluszko, P., Singhal, J., Carnoy, C., Moseley, S., Hudson, B., Nowicki, S., & Nowicki, B. (2004) · Infection and Immunity · doi:10.1128/iai.72.8.4827-4835.2004 · Cited by 66
Westerlund, B., van Die, I., Kramer, C., Kuusela, P., Holthöfer, H., Tarkkanen, A. ‐., Virkola, R., Riegman, N., Bergmans, H., Hoekstra, W., et al. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb01856.x · Cited by 59
Relatedness of Escherichia coli Colonizing Women Longitudinally
Navas-Nacher, E. L., Dardick, F., Venegas, M. F., Anderson, B. E., Schaeffer, A. J., & Duncan, J. L. (2001) · Molecular Urology · doi:10.1089/109153601750124285 · Cited by 30
Zalewska-Pia˛tek, B., Pia˛tek, R., Olszewski, M., & Kur, J. (2015) · Microbiology · doi:10.1099/mic.0.000072 · Cited by 15
Metadata
- Authors
- Johnson, J. R.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1991-01
- Volume
- 4
- Issue
- 1
- Pages
- 80-128
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W1990731735
- Cited by
- 1,290
- References
- 292
- FWCI
- 20.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.